On ECHEMI
Home > Drugs > Compound Bifendate Granules

Compound Bifendate Granules

Function and Efficacy

Bifendate is an intermediate in the synthesis of Schisandra chinensis propyl. Oral administration of 150-200 mg/kg of this product to mice can reduce liver damage caused by carbon tetrachloride and the increase of alanine aminotransferase (ALT). It has an inhibitory effect on liver microsomal lipid peroxidation caused by carbon tetrachloride and the conversion of carbon tetrachloride into carbon monoxide, and reduces the consumption of reduced coenzyme II and oxygen in the process of carbon tetrachloride metabolism, thereby protecting the structure and function of liver cell biomembrane. This product can also reduce the increase of liver ALT induced by prednisone and promote liver regeneration in mice with partial hepatectomy. The enzyme-lowering effect of this product does not directly inhibit the activity of serum and liver ALT, nor does it accelerate the inactivation of ALT in the blood, which may be a reflection of the reduction of liver tissue damage. This product has a significant induction effect on the activity of cytochrome P450 enzymes, thereby enhancing the detoxification ability of carbon tetrachloride and certain carcinogens. It has an effect on improving protein metabolism in some hepatitis patients, increasing albumin and reducing globulin. It has no negative conversion effect on HbsAg and HbeAg, and cannot shrink the enlarged liver and spleen. Inosine is the precursor of adenine. It can directly penetrate the cell membrane and enter the cell, and then be converted into inosinic acid and adenosine triphosphate. It participates in the energy metabolism and protein synthesis of liver cells, improves the activity of various enzymes, especially coenzyme A and pyruvate oxidase, activates liver function, and promotes the recovery of damaged liver. Vitamin C is involved in the formation of antibodies and collagen, tissue repair (including certain redox effects), the metabolism of phenylalanine, tyrosine, and folic acid, the utilization of iron and carbohydrates, the synthesis of fat and protein, and the maintenance of immune function.

Ingredients

This product is a compound preparation, and its components include bifendate, inosine and vitamin C in each bag.

Name Description Content CAS NO. Manufacturer
BifendateIngredients

Reduce liver damage and elevated alanine aminotransferase (ALT) caused by carbon tetrachloride; inhibit liver microsomal lipid peroxidation and carbon monoxide conversion caused by carbon tetrachloride; reduce the consumption of reduced coenzyme II and oxygen during carbon tetrachloride metabolism; protect the structure and function of liver cell biomembrane; promote liver regeneration in mice with partial hepatectomy; have a significant inducing effect on cytochrome P450 enzyme activity; enhance the detoxification ability of carbon tetrachloride and certain carcinogens; improve protein metabolism, increase albumin and reduce globulin; have no negative conversion effect on HbsAg and HbeAg, and cannot shrink enlarged liver and spleen.

More
73536-69-3 12
InosineIngredients

It directly penetrates the cell membrane and enters the cell, converting into inosinic acid and adenosine triphosphate; participates in liver cell energy metabolism and protein synthesis; increases the activity of various enzymes, especially coenzyme A and pyruvate oxidase; activates liver function; and promotes the recovery of damaged liver.

More
58-63-9 8
Ascorbic AcidIngredients

Participates in the formation of antibodies and collagen; tissue repair (including certain redox reactions); metabolism of phenylalanine, tyrosine, and folic acid; utilization of iron and carbohydrates; synthesis of fats and proteins; and maintenance of immune function.

More
50-81-7 28

Appearance

This product is light yellow granules with sweet taste.

Indication

Used for patients with chronic persistent hepatitis accompanied by elevated alanine aminotransferase (ALT).

Usage and Dosage

Oral administration. 10g each time. 3 times a day. Children should take a reduced dosage or follow the doctor's advice.

Adverse Reactions

Not yet clear.

Precautions

1. Those who are allergic to this product are prohibited from using it. 2. Those with liver cirrhosis are prohibited from using it. 3. Pregnant and lactating women are prohibited from using it.

Special Population Medication

Precautions for children: Reduce the dosage for children. Precautions for pregnancy and lactation: Pregnant and lactating women are prohibited. Precautions for the elderly: Elderly patients should use this product with caution.

Drug Interactions

Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.

Storage

Keep sealed.

Packaging Specification

Compound

Validity Period

24 months

Manufacturer

Heilongjiang Fuhe Pharmaceutical Group Co., Ltd.

  • Founded in:

    1994-12-28
  • Address:

    No. 1166, Zhengyang Street, Zhaodong City, Suihua City, Heilongjiang Province
  • Tax NO.:

    912312001313217015
  • Registered Funds:

    78.54 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.